We are looking for excellent distributors in MEA region!

Company news

As the silver partner of Medlab Series - Medical Laboratory Industry Forum 2021, we Bioperfectus today are happy to welcome excellentdistributorsinMiddle East &#Africaregion tocooperatewith us. Together we are navigating a healthier future for the entire human race.


The campaign including a special discount offer will officially start from today till the end of#medlab2021#online#meeting.


Send us an email atinfo@bioperfectusormarketing_global@bioperfectus.com to explore more information.


Click here to see our online booth at Medlab Online Matchmaking Platform now!



Bioperfectus Supports Cholera Elimination

SHANGHAI, CHINA, December 5, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”) is pleased to launch Vibrio Cholerae Real Time PCR Kits for human diagnosis and early warning surveillance.


Client Story: A Race Against Time

Through a critical assessment of clinical evaluation and data validation, Bioperfetus successfully passed the Israeli ministry of health inspection. Bioperfetus was the only Chinese company on the procurement list and was asked to provide one million antigen rapid test kits for the Israeli ministry of health.


Bioperfectus Granted MDA Approval in Malaysia for Nucleic Acid Extraction Systems

SHANGHAI, CHINA, November 14, 2022—Jiangsu Bioperfectus Technologies Co., Ltd. (hereinafter referred to as “Bioperfectus”), a leading global company in the molecular diagnostics market, today announced receipt of MDA (Medical Device Authority) approval in Malaysia for Nucleic Acid Extraction Systems, including Nucleic Acid SSNP-2000B, SSNP-3000A, SSNP-9600A, SMPE-960 and Extraction Rapid Kit (Magnetic Bead Method).